EBITDA for Danaher (DHR)
According to Danaher's latest reported financial statements, the company's current EBITDA (TTM) is $6.69B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
DHR
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$6.69B
YoY change
-4.5%
5Y CAGR
+1.2%
Peak year (2021)
$10.01B
Cumulative EBITDA
$104.00B
EBITDA history chart for Danaher (DHR) from 1985 to 2025
EBITDA history table for Danaher (DHR) from 1985 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $6.95B | -4.5% | ||
| 2024 | $7.28B | -3.0% | ||
| 2023 | $7.50B | -20.9% | ||
| 2022 | $9.48B | -5.2% | ||
| 2021 | $10.01B | +52.9% | ||
| 2020 | $6.54B | +42.1% | ||
| 2019 | $4.60B | +7.6% | ||
| 2018 | $4.28B | -1.5% | ||
| 2017 | $4.34B | +10.6% | ||
| 2016 | $3.92B | +28.2% | ||
| 2015 | $3.06B | -32.6% | ||
| 2014 | $4.54B | -1.4% | ||
| 2013 | $4.61B | +14.9% | ||
| 2012 | $4.01B | +24.3% | ||
| 2011 | $3.22B | +12.7% | ||
| 2010 | $2.86B | +51.4% | ||
| 2009 | $1.89B | -14.9% | ||
| 2008 | $2.22B | +10.1% | ||
| 2007 | $2.02B | +15.6% | ||
| 2006 | $1.74B | +19.7% | ||
| 2005 | $1.46B | +14.8% | ||
| 2004 | $1.27B | +29.5% | ||
| 2003 | $979.43M | +18.8% | ||
| 2002 | $824.41M | +9.9% | ||
| 2001 | $750.13M | +6.9% | ||
| 2000 | $701.87M | +20.1% | ||
| 1999 | $584.40M | +17.2% | ||
| 1998 | $498.70M | +45.4% | ||
| 1997 | $343.00M | +16.4% | ||
| 1996 | $294.80M | +23.5% | ||
| 1995 | $238.80M | +25.4% | ||
| 1994 | $190.50M | +42.3% | ||
| 1993 | $133.90M | +36.5% | ||
| 1992 | $98.10M | +44.1% | ||
| 1991 | $68.10M | -32.7% | ||
| 1990 | $101.20M | -10.5% | ||
| 1989 | $113.10M | -7.4% | ||
| 1988 | $122.20M | +24.7% | ||
| 1987 | $98.00M | +131.7% | ||
| 1986 | $42.30M | +58.4% | ||
| 1985 | $26.70M | — |
EBITDA values are taken from Danaher's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Danaher (DHR) reported EBITDA of $6.95B – edged down 4.5% year-over-year.
Across 2020–2025 (5 years), Danaher EBITDA produced a CAGR of +1.2% – with the latest reading among the more recent periods of the dataset.
Between 2021 and 2025, Danaher EBITDA plunged 30.6%, falling from $10.01B to $6.95B.
2021 marks the peak EBITDA at $10.01B, with the historical low of $26.70M recorded in 1985.
Among 8 Healthcare peers, Danaher (DHR) ranks 9th; the peer median for EBITDA is $24.21B.
Danaher EBITDA by Year
Danaher EBITDA 2025: $6.95B
Danaher EBITDA in 2025 was $6.95B, edged down 4.5% below 2024.
Danaher EBITDA 2024: $7.28B
Danaher EBITDA in 2024 was $7.28B, edged down 3.0% below 2023.
Danaher EBITDA 2023: $7.50B
Danaher EBITDA in 2023 was $7.50B, declined 20.9% below 2022.
Danaher EBITDA 2022: $9.48B
Danaher EBITDA in 2022 was $9.48B, declined 5.2% below 2021.
Danaher EBITDA 2021: $10.01B
Danaher EBITDA in 2021 was $10.01B.
See more financial history for Danaher (DHR).
Sector peers — EBITDA
Companies in the same sector as Danaher, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Danaher's EBITDA?
- Latest reported EBITDA for Danaher (DHR) is $6.69B (period ending March 27, 2026).
How has Danaher EBITDA changed year-over-year?
- Danaher (DHR) EBITDA changed -4.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Danaher EBITDA?
- Danaher (DHR) EBITDA compound annual growth rate is +1.2% over the most recent 5 years available.
When did Danaher EBITDA hit its highest annual value?
- Danaher EBITDA reached its highest annual value of $10.01B in 2021.
What was Danaher EBITDA in 2024?
- Danaher (DHR) EBITDA in 2024 was $7.28B.
What was Danaher EBITDA in 2025?
- Danaher (DHR) EBITDA in 2025 was $6.95B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DHR Overview
Company profile, financial tools, and key metrics
DHR Revenue Counter
Earns $785.71 every second. See per minute, hour, and day.
DHR Earnings Counter
Earns $116.98 per second net profit. See per minute, hour, and day.
DHR Economic Scale
Exceeds Guyana's GDP. Compare with world economies.
DHR What If Invested
What if you had invested $1,000? See historical returns from any date.
DHR How It Makes Money
Discover visual breakdown of $24.78B in revenue — where it comes from and where it goes.
DHR Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DHR Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DHR Daily Price Character
Balanced · 45.2% historical win rate (green days). Streaks & record days.
DHR Buybacks
1.57% TTM buyback yield. Shareholder yield & SBC comparison.
DHR Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
DHR Dividend Profile
Yield: 0.76%. Safety: 4/8. See full history.
DHR Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
DHR Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.